Hitech Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 08-07-2024
- Paid Up Capital ₹ 1.00 M
as on 08-07-2024
- Company Age 40 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.90 M
as on 08-07-2024
- Revenue %
(FY 2020)
- Profit -36.58%
(FY 2020)
- Ebitda -36.58%
(FY 2020)
- Net Worth -1.05%
(FY 2020)
- Total Assets %
(FY 2020)
About Hitech Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gautam Daftary and Siddharth Daftary serve as directors at the Company.
- CIN/LLPIN
U24230MH1984PTC032645
- Company No.
032645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 1984
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hitech Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Daftary  | Director | 12-Apr-1984 | Current |
| Siddharth Daftary | Director | 12-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Hitech Laboratories.
Hitech Laboratories Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 36.58% decrease in profit. The company's net worth dipped by a decrease of 1.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hitech Laboratories?
In 2020, Hitech Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rivaara Labs Private LimitedActive 5 years 2 monthsGautam Daftary and Siddharth Daftary are mutual person
Genei Laboratories Private LimitedActive 11 years 11 monthsGautam Daftary and Siddharth Daftary are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 01 Oct 1986 | ₹1.60 M | Satisfied |
Bank Of Baroda Creation Date: 31 Oct 1985 | ₹0.30 M | Satisfied |
How Many Employees Work at Hitech Laboratories?
Unlock and access historical data on people associated with Hitech Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hitech Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hitech Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
